- Researchers looked at deaths of people who had kidney transplants or were on waiting lists in 2019 and 2020
- One in every 10 people, or 11%, who were on the waiting list, died of COVID-19. caused by
- About one in six people, or 16% of transplant recipients, died of the virus.
- Non-Covid deaths in 2020 were more likely to occur in whites, while COVID deaths were more likely to occur in blacks and Hispanics
Kidney transplant recipients and people with kidney failure face a higher risk of dying from COVID-19, a new analysis finds.
Researchers at Columbia University Mailman School of Public Health in New York looked at nearly 325,000 people who had a kidney transplant or were on the waiting list and compared death rates from 2020 to 2019.
They found that 16 percent of deaths — or one in six — of those who received transplants in the US in 2020 were due to COVID-19.
In addition, one in 10 who were candidates for kidney transplants died of the virus.
The researchers looked at the deaths of people who had kidney transplants or were on waiting lists in 2019 and 2020. Pictured: Medical professionals pronounce a 39-year-old unrelated COVID-19 patient at St. Luke’s Boise Medical Center in Idaho. August 2021
One in every 10 people, or 11%, who were on the waiting list, died of COVID-19. caused by
About one in six people, or 16% of transplant recipients, died of the virus.
Dr Sumit Mohan, associate professor of medicine and epidemiology at the Columbia University Mailman School of Public Health, said: “This is the first analysis of national-level COVID-19-related mortality in transplant recipients and patients awaiting kidney transplants. a press release.
‘There was a large increase in deaths among these susceptible individuals with a disproportionate effect on minorities.’
For analysis, published in Clinical Journal of the American Society of NephrologyThe team looked at national registry data for kidney transplant recipients and waitlisted candidates from January 1, 2020 to April 23, 2021.
During this period, 190,481 received a donor kidney and 134,948 were on the transplant waiting list.
Next, they looked at deaths in 2020 for both groups and compared the numbers with pre-pandemic mortality in 2019.
The waitlisted candidates accounted for 3,865 deaths in 2019 and 4,774 in 2020.
Researchers determined that 516 of those deaths were linked to COVID-19, meaning that one out of every 10 people on the waiting list died due to the virus.
Those on the waiting list who died from COVID-19 were 65 percent more likely to be male than those on the list compared to 72 percent who died.
Additionally, 85 percent of all COVID-19 deaths on the waiting list were minorities, compared to 60 percent of those who died of other causes.
Only 15 percent of waiting list patients who died of the virus were white while 72 percent of deaths were among black or Hispanic candidates.
When it comes to kidney transplant recipients, there were 4,527 deaths in 2019 and 5,435 in 2020.
A total of 839 of those deaths were linked to COVID-19, meaning that nearly one in every six transplant recipients died due to the virus.
For both waitlisted candidates and transplant recipients, white patients were more likely to die from non-Covid causes and Hispanic and black patients were more likely to die from COVID
Similarly, transplant patients who died were more likely to be from communities of color than were Caucasians.
White recipients made up 54 percent of non-Covid deaths in 2020 and 59 percent in 2019, but only 30 percent of Covid deaths
By comparison, Hispanic and Black recipients made up 62 percent of Covid deaths, but just 39 percent of non-Covid deaths.
Previous research has shown an increased risk of death due to COVID-19 for patients with kidney problems.
An October 2020 study found that people with kidney disease have a three times higher risk of dying from COVID-19.
Researchers suspect that patients with kidney failure and those who recently had a transplant both have weakened immune systems that make them more vulnerable to COVID-19.
This is especially true for transplant patients, who have to be on a lifelong course of immunosuppressant drugs.